Condition: Concomitant Procedures · Atrial Fibrillation · PFA · Sponsor: Boston Scientific Corporation
Subjects enrolled in the OPTION-A study will be clinically indicated for atrial fibrillation (AF) ablation procedure with the FARAPULSE™ PFA system and treatment with WATCHMAN LAAC Device, per physician's medical judgement and according to hospitals' standard of care during the same procedure.
This description comes directly from the study's public registry record.
Jamie Kwek · +6564188833 · Jamie.Kwek@bsci.com
Always discuss trial participation with your own doctor first.
| The First Affiliated Hospital of Soochow University | Suzhou, Jiangsu, China | Recruiting |
| Beijing Anzhen Hospital of the Capital University of Medical Sciences | Beijing, China | Recruiting |
| Xuanwu Hospital Capital Medical University | Beijing, China | Recruiting |
| Huaxi Hospital of Sichuan University | Chengdu, China | Active Not Recruiting |
| The First Affiliated Hospital of Chengdu Medical College | Chengdu, China | Recruiting |
| Guangdong Nanfang Hospital | Guangzhou, China | Recruiting |
| The Third Affiliated Hospital of Guangzhou Medical University | Guangzhou, China | Recruiting |
| The Affiliated Hospital of Guizhou Medical University | Guiyang, China | Recruiting |
| Sir Run Run Shaw Hospital of Zhejiang University School of Medicine | Hangzhou, China | Recruiting |
| QiLu Hospital of ShanDong University | Jinan, China | Recruiting |
| First People's Hospital of Yunnan Province | Kunming, China | Recruiting |
| Affiliated Hospital of Nantong University | Nantong, China | Recruiting |
+ 25 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06686485